LFST as reported
LifeStance Health Group, Inc. reported $1.58B of revenue over the trailing twelve months, +20% on the year before. 9 reported series are charted on this page, each one as filed.
$1.58B
Revenue, trailing twelve months · to Q2 2026 · +20% against the twelve months before
- Net Income
- $51M
Net Income · −633% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $174M
Free Cash Flow · +45% year on year · trailing twelve months to Q2 2026
- Op Margin
- 4.8%
Op Margin · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $1.58B | +20% | Q2 2026 |
| Net Income | $51M | −633% | Q2 2026 |
| EPS | $0.13 | −360% | Q2 2026 |
| Op Margin | 4.8% | n/a | Q2 2026 |
| Net Margin | 3.1% | n/a | Q2 2026 |
| ROE | 1.3% | n/a | Q2 2026 |
| ROA | 0.85% | n/a | Q2 2026 |
| ROIC | 2.0% | n/a | Q2 2026 |
| Free Cash Flow | $174M | +45% | Q2 2026 |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
LifeStance Health Group, Inc. (LFST) - Revenue & ProfitRevenue & ProfitLifeStance Health Group, Inc. (LFST)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Care Facilities
Ranks #13 of 28 by Smart Score